2012 New York Consolidated Laws
PBH - Public Health
Article 2-A - PRESCRIPTION DRUGS
Title 1 - (270 - 277) PREFERRED DRUG AND CLINICAL DRUG REVIEW PROGRAMS
277 - Review and reports.

 
    §  277.  Review and reports. 1. The commissioner, in consultation with
  the  pharmacy  and  therapeutics  committee,  shall  undertake  periodic
  reviews,  at  least  annually, of the preferred drug program which shall
  include consideration of:
    (a) the volume of prior authorizations being handled,  including  data
  on  the  number  and characteristics of prior authorization requests for
  particular prescription drugs;
    (b) the quality of the program's responsiveness, including the quality
  of the administrator's responsiveness;
    (c) complaints received from patients and providers;
    (d) the savings attributable to the state, and to each county and  the
  city of New York, due to the provisions of this article;
    (e)  the  aggregate  amount  of  supplemental  rebates received in the
  previous fiscal year and in the current fiscal year, to date;  and  such
  amounts are to be broken out by fiscal year and by month;
    (f)  the  education  and  outreach  program established by section two
  hundred seventy-six of this article.
    2. The commissioner and the panel shall, beginning March thirty-first,
  two thousand six  and  annually  thereafter,  submit  a  report  to  the
  governor  and  the  legislature  concerning each of the items subject to
  periodic review under subdivision one of this section.
    3.  The  commissioner  and  the  panel  shall,  beginning   with   the
  commencement  of  the  preferred  drug  program  and monthly thereafter,
  submit a report to the  governor  and  the  legislature  concerning  the
  amount of supplemental rebates received.